Stock CARM CARISMA THERAPEUTICS, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Analyst Reco. Carisma Therapeutics, Inc.

Equities

CARM

US14216R1014

Delayed Nasdaq
Other stock markets
 02:59:05 2024-05-03 pm EDT 		5-day change 1st Jan Change
1.6 USD 0.00% Intraday chart for Carisma Therapeutics, Inc. -2.44% -45.39%
May. 02 Carisma Therapeutics Appoints Dr. Eugene P. Kennedy as Chief Medical Officer CI
Apr. 11 BTIG Starts Carisma Therapeutics With Buy Rating, $6 Price Target MT

Analyst Reco.

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
BTIG Starts Carisma Therapeutics With Buy Rating, $6 Price Target
MT
HC Wainwright Adjusts Price Target on Carisma Therapeutics to $9 From $11, Maintains Buy Rating
MT
Capital Starts Carisma Therapeutics at Overweight With $10 Price Target
MT
HC Wainwright Adjusts Price Target on CARISMA Therapeutics to $11 From $10, Keeps Buy Rating
MT
Evercore ISI Initiates CARISMA Therapeutics at Outperform With $12 Price Target
MT
HC Wainwright Starts Carisma Therapeutics at Buy With $10 Price Target
MT
Baird Initiates CARISMA Therapeutics at Outperform With $10 Price Target
MT
SESEN BIO : Jefferies & Co Downgrades Sesen Bio to Hold From Buy, Adjusts PT to $1.50 From $6
MT
SESEN BIO : Canaccord Genuity Adjusts Sesen Bio PT to $3 From $7, Maintains Buy Rating
MT
SESEN BIO : HC Wainwright Downgrades Sesen Bio to Neutral From Buy
MT
SESEN BIO : Jefferies Adjusts Price Target for Sesen Bio to $6 From $3, Maintains Buy Rating
MT
SESEN BIO : Canaccord Adjusts Sesen Bio's Price Target to $7 from $5, Keeps Buy Rating
MT
SESEN BIO : HC Wainwright Adjusts Sesen Bio's Price Target to Street-High $8 From $2.25, Keeps Buy Rating
MT
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. CARM Stock
  4. News Carisma Therapeutics, Inc.
  5. Analyst Reco.